4//SEC Filing
Kalra Balkrishan 4
Accession 0001768217-25-000004
CIK 0001398659other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 4:10 PM ET
Size
10.2 KB
Accession
0001768217-25-000004
Insider Transaction Report
Form 4
Kalra Balkrishan
DirectorPresident and CEO
Transactions
- Sale
Common Shares
2025-09-11$43.35/sh−40,000$1,734,000→ 295,246 total - Sale
Common Shares
2025-09-11$43.39/sh−15,000$650,850→ 295,246 total - Exercise/Conversion
Common Shares
2025-09-11$27.65/sh+40,000$1,106,000→ 335,246 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-09-11−40,000→ 2,800 totalExercise: $27.65Exp: 2026-03-31→ Common Shares (40,000 underlying)
Footnotes (3)
- [F1]The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.39 to $43.40. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F2]The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.29 to $43.42. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The option vested 50% on January 10, 2019 and the remainder on January 10, 2021.
Documents
Issuer
Genpact LTD
CIK 0001398659
Entity typeother
Related Parties
1- filerCIK 0001768217
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 4:10 PM ET
- Size
- 10.2 KB